LYRA - Lyra Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LYRA is currently covered by 1 analysts with an average price target of $316.93. This is a potential upside of $314.73 (14305.91%) from yesterday's end of day stock price of $2.2.

Lyra Therapeutics 's activity chart (see below) currently has 12 price targets and 21 ratings on display. The stock rating distribution of LYRA is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 65.33 days.

Highest price target for LYRA is $16, Lowest price target is $16, average price target is $16.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 14-Aug-2025. First documented stock forecast 26-May-2020.

Best performing analysts who are covering LYRA - Lyra Therapeutics :

Jason Gerberry Robert Hazlett Matthew Caufield Louise Chen Dennis Ding Justin Zelin

Currently out of the existing stock ratings of LYRA, 3 are a HOLD (100%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 07-May-2024

$16

$14.01 (704.02%)

$16

5 months 9 days ago
(14-Aug-2025)

0/6 (0%)

$8.9 (125.35%)

Buy

Since 24-May-2022

1 years 5 months 8 days ago
(15-Aug-2024)

0/1 (0%)

$450 (150.00%)

Hold

Since 07-May-2024

$25

$23.01 (1156.28%)

1 years 8 months 16 days ago
(07-May-2024)

1/1 (100%)

$4 (19.05%)

392

Hold

Since 06-May-2024

$750

1 years 8 months 17 days ago
(06-May-2024)

0/1 (0%)

$568 (312.09%)

Buy

Since 26-May-2020

$550

1 years 8 months 21 days ago
(02-May-2024)

0/3 (0%)

$242 (78.57%)

Show more analysts

Please expand the browser size to see the chart

What is LYRA (Lyra Therapeutics ) average time for price targets to be met?

On average it took 65.33 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JASON GERBERRY

Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?

Jason Gerberry works at BAML and has 5 price targets and 3 ratings on LYRA

Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?

Dennis Ding with highest potential upside - $23.01

Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?

Jason Gerberry with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?